Expert Review of Pharmacoeconomics & Outcomes Research, Volume 15, Issue 3 (2015)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Review of Pharmacoeconomics & Outcomes Research, Volume 15, Issue 3 (2015)

See all volumes and issues
Vol 24, 2024 Vol 23, 2023 Vol 22, 2022 Vol 21, 2021 Vol 20, 2020 Vol 19, 2019 Vol 18, 2018 Vol 17, 2017 Vol 16, 2016 Volume 15, 2015 Vol 14, 2014 Vol 13, 2013 Vol 12, 2012 Vol 11, 2011 Vol 10, 2010 Vol 9, 2009 Vol 8, 2008 Vol 7, 2007 Vol 6, 2006 Vol 5, 2005 Vol 4, 2004 Vol 3, 2003 Vol 2, 2002 Vol 1, 2001
Download citations Download PDFs Download issue

Editorials

Editorial
A national incident reporting and learning system in England and Wales, but at what cost?
Alexander W Carter, Elias Mossialos & Ara Darzi
Pages: 365-368
Published online: 03 Apr 2015
AbstractforA national incident reporting and learning system in England and Wales, but at what cost? | Full Text | References | PDF (274.7 KB)
  • 2368 Views
  • 2 CrossRef citations
  • 0Altmetric
Free Access
Editorial
How can we assess the value of complex medical innovations in practice?
Payam Abrishami, Albert Boer & Klasien Horstman
Pages: 369-371
Published online: 12 May 2015
AbstractforHow can we assess the value of complex medical innovations in practice? | Full Text | References | PDF (154.9 KB)
  • 1617 Views
  • 6 CrossRef citations
  • 0Altmetric
Free Access

Drug Profiles

The economics of adalimumab for ulcerative colitis
Feng Xie
Pages: 373-377
Published online: 30 Mar 2015
AbstractforThe economics of adalimumab for ulcerative colitis | Full Text | References | PDF (189.3 KB)
  • 206 Views
  • 0 CrossRef citations
  • 0Altmetric
Cost-effectiveness of Sativex in multiple sclerosis spasticity: new data and application to Italy
John Slof, Leonardo Ruiz & Carlos Vila
Pages: 379-391
Published online: 16 Mar 2015
AbstractforCost-effectiveness of Sativex in multiple sclerosis spasticity: new data and application to Italy | Full Text | References | PDF (721.6 KB)
  • 220 Views
  • 13 CrossRef citations
  • 0Altmetric

Letters to the Editor

Genomic profile of breast cancer
Juliette Plun-Favreau, Christer Svedman, William Valentine & Roman Rouzier
Pages: 393-394
Published online: 23 Mar 2015
CitationforGenomic profile of breast cancer | Full Text | References | PDF (136.9 KB)
  • 573 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access
In response: Genomic profile of breast cancer
Miguel Angel Seguí, Carlos Crespo, Javier Cortés, Ana Lluch, Max Brosa, Virginia Becerra, Sebastián Chiavenna & Alfredo Gracia
Pages: 395-397
Published online: 22 Mar 2015
First Page PreviewforIn response: Genomic profile of breast cancer | Full Text | References | PDF (162.6 KB)
  • 668 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access

Special Reports

Report
The lag from FDA approval to published cost-utility evidence
James D Chambers, Teja Thorat, Junhee Pyo & Peter J Neumann
Pages: 399-402
Published online: 12 Jan 2015
AbstractforThe lag from FDA approval to published cost-utility evidence | Full Text | References | PDF (449 KB)
  • 119 Views
  • 7 CrossRef citations
  • 0Altmetric
Report
Poorer functionality is related to better quality of life response following the use of biological drugs: 6-month outcomes in a prospective cohort from the Public Health System (Sistema Único de Saúde), Minas Gerais, Brazil
Haliton Alves de Oliveira Junior, Jéssica Barreto dos Santos, Francisco Assis Acurcio, Alessandra Maciel Almeida, Adriana Maria Kakehasi, Juliana Alvares, Luis Fernando Duarte de Carvalho & Mariangela Leal Cherchiglia
Pages: 403-412
Published online: 20 Jan 2015
AbstractforPoorer functionality is related to better quality of life response following the use of biological drugs: 6-month outcomes in a prospective cohort from the Public Health System (Sistema Único de Saúde), Minas Gerais, Brazil | Full Text | References | PDF (250 KB)
  • 93 Views
  • 9 CrossRef citations
  • 0Altmetric

Reviews

Review
A review of cost–effectiveness comparisons for overactive bladder treatments: which is the most cost-effective for improving quality of life?
Konstantinos Giannitsas & Anastasios Athanasopoulos
Pages: 413-423
Published online: 06 Feb 2015
AbstractforA review of cost–effectiveness comparisons for overactive bladder treatments: which is the most cost-effective for improving quality of life? | Full Text | References | PDF (265.4 KB)
  • 155 Views
  • 4 CrossRef citations
  • 0Altmetric
Review
Methods to control the pharmaceutical cost impact of chronic conditions in the elderly
David Vivas-Consuelo, Ruth Usó-Talamantes, José Luis Trillo-Mata & Pablo Mendez-Valera
Pages: 425-437
Published online: 23 Feb 2015
AbstractforMethods to control the pharmaceutical cost impact of chronic conditions in the elderly | Full Text | References | PDF (538 KB)
  • 173 Views
  • 2 CrossRef citations
  • 0Altmetric
Review
The economic impact of amyotrophic lateral sclerosis: a systematic review
Matthew Gladman & Lorne Zinman
Pages: 439-450
Published online: 30 Apr 2015
AbstractforThe economic impact of amyotrophic lateral sclerosis: a systematic review | Full Text | References | PDF (346.3 KB)
  • 1076 Views
  • 53 CrossRef citations
  • 0Altmetric
Review
Do different decision-analytic modeling approaches produce different results? A systematic review of cross-validation studies
Bernice Tsoi, Ron Goeree, Jathishinie Jegathisawaran, Jean-Eric Tarride, Gord Blackhouse & Daria O’Reilly
Pages: 451-463
Published online: 02 Mar 2015
AbstractforDo different decision-analytic modeling approaches produce different results? A systematic review of cross-validation studies | Full Text | References | PDF (355.5 KB) | Supplemental
  • 236 Views
  • 3 CrossRef citations
  • 0Altmetric
Review
Incorporation of future costs in health economic analysis publications: current situation and recommendations for the future
Blanca Gros, Javier Soto Álvarez & Miguel Ángel Casado
Pages: 465-469
Published online: 03 Mar 2015
AbstractforIncorporation of future costs in health economic analysis publications: current situation and recommendations for the future | Full Text | References | PDF (437.3 KB)
  • 210 Views
  • 5 CrossRef citations
  • 0Altmetric

Review

Review
Racial variation in the clinical and economic burden of skeletal-related events among elderly men with stage IV metastatic prostate cancer
Jinani Jayasekera, Eberechukwu Onukwugha, Kaloyan Bikov & Arif Hussain
Pages: 471-485
Published online: 30 Mar 2015
AbstractforRacial variation in the clinical and economic burden of skeletal-related events among elderly men with stage IV metastatic prostate cancer | Full Text | References | PDF (623.3 KB) | Supplemental
  • 137 Views
  • 3 CrossRef citations
  • 0Altmetric

Reviews

Review
Impact of cardiovascular complications among patients with Type 2 diabetes mellitus: a systematic review
Varun Vaidya, Nilesh Gangan & Jack Sheehan
Pages: 487-497
Published online: 31 Mar 2015
AbstractforImpact of cardiovascular complications among patients with Type 2 diabetes mellitus: a systematic review | Full Text | References | PDF (761.5 KB) | Supplemental
  • 1276 Views
  • 74 CrossRef citations
  • 0Altmetric

Research Reports

Report
Quality of life in pediatric asthma patients and their parents: a meta-analysis on 20 years of research
Neuza Silva, Carlos Carona, Carla Crespo & Maria Cristina Canavarro
Pages: 499-519
Published online: 05 Feb 2015
AbstractforQuality of life in pediatric asthma patients and their parents: a meta-analysis on 20 years of research | Full Text | References | PDF (981.2 KB) | Supplemental
  • 290 Views
  • 24 CrossRef citations
  • 0Altmetric
Article
Evolution of the Serbian pharmaceutical market alongside socioeconomic transition
Mihajlo B Jakovljevic, Natasa Djordjevic, Milena Jurisevic & Slobodan Jankovic
Pages: 521-530
Published online: 16 Jan 2015
AbstractforEvolution of the Serbian pharmaceutical market alongside socioeconomic transition | Full Text | References | PDF (233.8 KB)
  • 104 Views
  • 34 CrossRef citations
  • 0Altmetric
Article
Osteoporosis in German men: a cost-of-illness study
Sabine Berghaus, Dirk Müller, Afschin Gandjour, Daniele Civello & Stephanie Stock
Pages: 531-537
Published online: 11 Dec 2014
AbstractforOsteoporosis in German men: a cost-of-illness study | Full Text | References | PDF (208 KB) | Supplemental
  • 170 Views
  • 3 CrossRef citations
  • 0Altmetric
Article
Cost–effectiveness analysis of 5-fluorouracil 0.5%/salicylic acid 10% in the treatment of actinic keratosis in Spain
Diana Nieves, Ruth Puig-Peiró, Carlos Ferrándiz, Maria Josep Plazas & Max Brosa
Pages: 539-543
Published online: 13 Dec 2014
AbstractforCost–effectiveness analysis of 5-fluorouracil 0.5%/salicylic acid 10% in the treatment of actinic keratosis in Spain | Full Text | References | PDF (307.8 KB)
  • 146 Views
  • 6 CrossRef citations
  • 0Altmetric
Article
Phosphorus binding with ferric citrate is associated with fewer hospitalizations and reduced hospitalization costs
Roger Rodby, Kausik Umanath, Robert Niecestro, James H Jackson, Mohammed Sika, Julia B Lewis, Jamie P Dwyer & for the Collaborative Study Group
Pages: 545-550
Published online: 13 Dec 2014
AbstractforPhosphorus binding with ferric citrate is associated with fewer hospitalizations and reduced hospitalization costs | Full Text | References | PDF (597.8 KB)
  • 471 Views
  • 21 CrossRef citations
  • 0Altmetric
Open Access

Explore articles